RecruitingNot ApplicableNCT06280885
A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy
Sponsor
University of Dublin, Trinity College
Enrollment
50 participants
Start Date
Jan 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The primary aim of this study is to measure the feasibility of delivering a co-designed exercise programme for patients with cancer receiving chemotherapy treatment.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Aged >18.
- Histological confirmed diagnosis of stage I to IIIc breast, ovarian or colorectal cancer.
- Scheduled to receive chemotherapy ± immunotherapy with curative intent.
- Medical clearance from oncologist to partake in regular exercise in accordance with American College of Sports Medicine (ACSM) preparticipation screening algorithm.
- Ability to provide written informed consent.
Exclusion Criteria3
- Advanced/metastatic disease.
- Scheduled to receive concurrent chemoradiotherapy.
- Scheduled to receive high-dose chemotherapy during hospital admission.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALExercise
Participants will be randomised to either the FIERCE exercise programme involving supervised exercise prescription
BEHAVIORALHealth Behaviour Change (Pedometer)
Participants in both arms will be provided with a pedometer as a health behaviour change intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06280885
Related Trials
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
NCT056946501 location
Connect for Cancer Prevention Study (Connect)
NCT0460907210 locations
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
NCT075785712 locations
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
NCT011434801 location
Support for Bereaved Cancer Caregivers
NCT066624091 location